about
Loss of protein kinase C-δ protects against LPS-induced osteolysis owing to an intrinsic defect in osteoclastic bone resorptionEGFL6 promotes endothelial cell migration and angiogenesis through the activation of extracellular signal-regulated kinase.Choline kinase β mutant mice exhibit reduced phosphocholine, elevated osteoclast activity, and low bone massProtein kinase C delta null mice exhibit structural alterations in articular surface, intra-articular and subchondral compartments.Natural Germacrane Sesquiterpenes Inhibit Osteoclast Formation, Bone Resorption, RANKL-Induced NF-κB Activation, and IκBα Degradation.Berberine Sulfate Attenuates Osteoclast Differentiation through RANKL Induced NF-κB and NFAT Pathways.Morc3 mutant mice exhibit reduced cortical area and thickness, accompanied by altered haematopoietic stem cells niche and bone cell differentiation.NPNT is Expressed by Osteoblasts and Mediates Angiogenesis via the Activation of Extracellular Signal-regulated Kinase.Nitidine chloride prevents OVX-induced bone loss via suppressing NFATc1-mediated osteoclast differentiation.Calmodulin interacts with Rab3D and modulates osteoclastic bone resorption.Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT.An overview of the regulation of bone remodelling at the cellular level.Angiogenic factors in bone local environment.The role of SATB2 in skeletogenesis and human disease.The Emerging Role of MORC Family Proteins in Cancer Development and Bone Homeostasis.Triptolide inhibits osteoclast formation, bone resorption, RANKL-mediated NF-қB activation and titanium particle-induced osteolysis in a mouse model.Protein kinase C inhibitor, GF109203X attenuates osteoclastogenesis, bone resorption and RANKL-induced NF-κB and NFAT activity.EGFL7 is expressed in bone microenvironment and promotes angiogenesis via ERK, STAT3, and integrin signaling cascades.Molecular structure and differential function of choline kinases CHKα and CHKβ in musculoskeletal system and cancer.Mechanical Stress Regulates Bone Metabolism Through MicroRNAs.HtrA1 is upregulated during RANKL-induced osteoclastogenesis, and negatively regulates osteoblast differentiation and BMP2-induced Smad1/5/8, ERK and p38 phosphorylation.SC-514, a selective inhibitor of IKKβ attenuates RANKL-induced osteoclastogenesis and NF-κB activation.The emerging role of NPNT in tissue injury repair and bone homeostasis.Nox2-derived ROS in PPARγ signaling and cell-cycle progression of lung alveolar epithelial cells.Bafilomycin A1 Attenuates Osteoclast Acidification and Formation, Accompanied by Increased Levels of SQSTM1/p62 Protein.Eriodictyol Inhibits RANKL-Induced Osteoclast Formation and Function Via Inhibition of NFATc1 Activity.Luteoloside prevents lipopolysaccharide-induced osteolysis and suppresses RANKL-induced osteoclastogenesis through attenuating RANKL signaling cascades.Dihydroartemisinin, an Anti-Malaria Drug, Suppresses Estrogen Deficiency-Induced Osteoporosis, Osteoclast Formation, and RANKL-Induced Signaling Pathways.Cyanidin Chloride inhibits ovariectomy-induced osteoporosis by suppressing RANKL-mediated osteoclastogenesis and associated signaling pathways.Achyranthes bidentata polysaccharide suppresses osteoclastogenesis and bone resorption via inhibiting RANKL signaling.Neohesperidin suppresses osteoclast differentiation, bone resorption and ovariectomised-induced osteoporosis in mice.Expression Quantitative Trait Locus Study of Bone Mineral Density GWAS Variants in Human Osteoclasts.EGFL7: Master regulator of cancer pathogenesis, angiogenesis and an emerging mediator of bone homeostasis.Helvolic acid attenuates osteoclast formation and function via suppressing RANKL-induced NFATc1 activationMadecassoside inhibits estrogen deficiency-induced osteoporosis by suppressing RANKL-induced osteoclastogenesisUse of the collaborative cross gene mine mouse phenotype library to identify novel genes regulating bone mass and bone architectureGenetic regulatory mechanisms in human osteoclasts suggest a role for the STMP1 and DCSTAMP genes in Paget's disease of boneAdvanced Genetic Approaches in Discovery and Characterization of Genes Involved With Osteoporosis in Mouse and HumanPseurotin A Inhibits Osteoclastogenesis and Prevents Ovariectomized-Induced Bone Loss by Suppressing Reactive Oxygen SpeciesAn effective and practical immunohistochemical protocol for bone specimens characterized by hyaluronidase and pepsin predigestion combined with alkaline phosphatase-mediated chromogenic detection
P50
Q34947739-976856D8-E0FE-46F1-92B1-BCD27303E97EQ35063005-1DD3A2E1-0C4A-49F9-88C8-62AD415DCE41Q35121332-20CB83C9-0884-400E-9697-A4DAC2E3D7CCQ35962168-94E1E84D-5B90-4A50-AC9C-F98F2CBED89FQ36324551-4103DEC1-5635-4DCA-A646-94D90242B3A3Q36324625-EC18A382-E0D3-4AE6-9E6C-C60CDAAB0098Q36910565-EE1D8A3F-BAF6-4C03-B2DB-C6BB9BED2B3FQ37366894-F9451903-EB53-4F98-AF39-723D9B0C708CQ37399717-D1427374-A7E4-41B0-B0E1-B33E03313D00Q37448923-C2B89283-8E92-4AA5-9332-149936D1CC14Q37631691-78468F20-F03D-4B31-9F57-2C9FD019339FQ37998757-67145F9F-2CFC-4525-92C7-F3AF7C40BAC0Q38101152-AB5DD4CD-45EB-4A56-886B-49A06A30D82CQ38177439-E9A97230-F913-429A-B20B-A700C0C4C1A2Q38803154-AC105A88-8F1F-40FB-BBC6-6FCFC79A7E9BQ38935113-EEC33BBB-2886-4CB8-90B9-C53621E1E337Q38943284-CD764F32-08A2-4804-B9CA-AD0D9777813FQ38987168-1FED09E3-B69B-44D4-A96B-0B4B2F81DD7FQ38987792-B91EBBDF-9398-4E62-BBAF-ED0E086A1EC1Q39012805-D483C4E0-C9EA-45D1-ADB8-B970D22E630EQ39056806-DF3F00E3-1C0A-482A-BA27-14A71EAFF2B3Q39088267-EAE70FE0-A7DF-43E8-AE5A-A015C40640B1Q39312857-37635141-A0F0-4D05-B466-23662E2F9FF6Q39526488-A95A9221-8CB6-47BD-9F49-9C53CE6B346FQ39865069-8A79A4D9-E534-4584-BD6D-22E838489BF9Q40120415-77F2E68A-BB5B-43FA-84A1-67F218540897Q40145765-89DFB798-F3BE-40B5-A0B5-19F0DBF7E5FAQ47940565-35DE783C-74F2-4735-B242-6AE529BC4AF1Q47995224-E745491A-89BC-4CA9-A634-1B1ACA3C0CACQ49973293-7A1C2129-E063-4502-BC08-E5B16F328BCAQ51467164-5CBAD8EB-AA4D-40C0-A4D7-30BB1DA92782Q52374241-2B659670-9621-499F-9B6E-413434764F4CQ55456799-BA3C8C73-F427-4204-8313-FE1F695E8D02Q57808358-045EFE3E-FF4E-4B13-A641-E97BDE66B824Q58588319-1AE0A25C-4EA5-4D9B-B000-B4ADD5B5ABDDQ59590836-A38E03AE-2E58-4D18-863E-9EEB59F2E4A6Q61805607-7EF793C0-959A-4B04-9355-ED86B3775284Q64084429-2E3284F9-B3DE-4B8F-B876-45401374FE54Q64093297-F6EEF22F-D509-484C-AF1E-5DC6CF9CA2D2Q85672802-19130850-561A-4BC5-A13C-DAB47EAE09DB
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jennifer Tickner
@ast
Jennifer Tickner
@en
Jennifer Tickner
@es
Jennifer Tickner
@nl
type
label
Jennifer Tickner
@ast
Jennifer Tickner
@en
Jennifer Tickner
@es
Jennifer Tickner
@nl
prefLabel
Jennifer Tickner
@ast
Jennifer Tickner
@en
Jennifer Tickner
@es
Jennifer Tickner
@nl
P106
P1153
55651395400
P21
P31
P496
0000-0002-5020-0671